4.7 Article

Accelerating the development of implantable neurochemical biosensors by using existing clinically applied depth electrodes

Journal

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 415, Issue 6, Pages 1137-1147

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-022-04445-1

Keywords

Enzymes; Amperometric biosensors; In vivo implantation; Neurotransmitters

Ask authors/readers for more resources

In this study, researchers functionalised an implantable stereo-electroencephalography (sEEG) depth electrode with an enzyme coating for enzyme-based biosensing of glucose and L-glutamate. Through characterisation using various electrochemical methods, they demonstrated that the modified electrode exhibited good electrochemical response and sensitivity to glucose and L-glutamate concentration, providing more accurate information for the treatment of neurological disorders. The findings suggest that existing clinical electrode devices can be adapted for combined electrochemical and electrophysiological measurements, accelerating the application of in vivo and wearable biosensing for diagnosis, treatment, and personalised medicine.
In this study, an implantable stereo-electroencephalography (sEEG) depth electrode was functionalised with an enzyme coating for enzyme-based biosensing of glucose and L-glutamate. This was done because personalised medicine could benefit from active real-time neurochemical monitoring on small spatial and temporal scales to further understand and treat neurological disorders. To achieve this, the sEEG depth electrode was characterised using cyclic voltammetry (CV), differential pulse voltammetry (DPV), square wave voltammetry (SWV), and electrochemical impedance spectroscopy (EIS) using several electrochemical redox mediators (potassium ferri/ferrocyanide, ruthenium hexamine chloride, and dopamine). To improve performance, the Pt sensors on the sEEG depth electrode were coated with platinum black and a crosslinked gelatin-enzyme film to enable enzymatic biosensing. This characterisation work showed that producing a useable electrode with a good electrochemical response showing the expected behaviour for a platinum electrode was possible. Coating with Pt black improved the sensitivity to H2O2 over unmodified electrodes and approached that of well-defined Pt macro disc electrodes. Measured current showed good dependence on concentration, and the calibration curves report good sensitivity of 29.65 nA/cm(2)/mu M for glucose and 8.05 nA/cm(2)/mu M for L-glutamate with a stable, repeatable, and linear response. These findings demonstrate that existing clinical electrode devices can be adapted for combined electrochemical and electrophysiological measurement in patients and obviate the need to develop new electrodes when existing clinically approved devices and the associated knowledge can be reused. This accelerates the time to use and application of in vivo and wearable biosensing for diagnosis, treatment, and personalised medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available